Real-World Analysis of Teclistamab Treatment for Relapsed Refractory Multiple Myeloma in Two Belgian University Hospitals

被引：0
|
作者：
Jadot, Gaspard [1 ]
Depaus, Julien [2 ]
Vekemans, Marie-Christiane [2 ,3 ]
机构：
[1] Clin Univ St Luc, Brussels, Belgium
[2] Univ Catholic Louvain, Dept Haematol, CHU UCL Namur, Yvoir, Belgium
[3] Univ Catholic Louvain, UCLouvain, Brussels, Belgium
来源：
CLINICAL LYMPHOMA MYELOMA & LEUKEMIA | 2024年 / 24卷
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P-032
引用
收藏
页码：S59 / S59
页数：1
相关论文
共 50 条
  • [1] Real-World Evaluation of Teclistamab for the Treatment of Relapsed/Refractory Multiple Myeloma (RRMM)
    Asoori, Sireesha
    Popat, Rakesh
    Martinez-Lopez, Joaquin
    Kastritis, Efstathios
    Brunaldi, Larissa
    Bansal, Radhika
    Corraes, Andre De Menezes Silva
    Yong, Kwee
    Mactier, Catriona
    Corona, Magdalena
    Saez Marin, Adolfo Jesus
    Fotiou, Despina
    Dimopoulos, Meletios Athanasios
    Chhabra, Saurabh
    Ailawadhi, Sikander
    Parrondo, Ricardo
    Martin, Thomas
    Durie, Brian G. M.
    Lin, Yi
    BLOOD, 2023, 142
  • [2] Real World Evaluation of Teclistamab for the Treatment of Relapsed or Refractory Multiple Myeloma (RRMM)
    Maringanti, Sireesha Asoori
    Lin, Yi
    Estritis, Stathis
    Martinez-Lopez, Joaquin
    Bansal, Radhika
    Fotiou, Despina
    Corona, Magdalena
    Chhabra, Saurabh
    Brunaldi, Larissa
    Corraes, Andre De Menezes Silva
    Parrondo, Ricardo
    Kapoor, Prashant
    Ailawadhi, Sikander
    Mas, Reyes
    Tamayo, Andrea
    Dimopoulos, Meletios
    Durie, Brian
    Martin, Thomas
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2023, 23 : S506 - S507
  • [3] Teclistamab for Relapsed/Refractory Multiple Myeloma: Real-World Experience in an Early Access Program
    Uttervall, Katarina
    Nahi, Hareth
    Kashif, Muhammad
    Lemonakis, Konstantinos
    Rosengren, Sara
    Brolin, Janaki
    Lund, Johan
    Hansson, Markus
    BLOOD, 2022, 140 : 12605 - 12606
  • [4] Safety and Efficacy of Teclistamab in Patients with Relapsed/ Refractory Multiple Myeloma: A Real-World Experience
    Dima, Danai
    Davis, James A.
    Ahmed, Nausheen
    Jia, Xuefei
    Sannareddy, Aishwarya
    Shaikh, Hira
    Shune, Leyla
    Kaur, Gurbakhash
    Khouri, Jack
    Afrough, Aimaz
    Strouse, Christopher
    Lochner, Jonathan
    Mahmoudjafari, Zahra
    Raza, Shahzad
    Valent, Jason
    Anderson Jr, Larry D.
    Anwer, Faiz
    Abdallah, Al-Ola
    Hashmi, Hamza
    TRANSPLANTATION AND CELLULAR THERAPY, 2024, 30 (03): : 308.e1 - 308.e13
  • [5] Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
    Meera Mohan
    Jorge Monge
    Nishi Shah
    Danny Luan
    Mark Forsberg
    Vineel Bhatlapenumarthi
    Metodi Balev
    Anannya Patwari
    Heloise Cheruvalath
    Divaya Bhutani
    Sharmilan Thanendrarajan
    Binod Dhakal
    Maurizio Zangari
    Samer Al-Hadidi
    Dennis Cooper
    Suzanne Lentzsch
    Frits van Rhee
    Anita D’Souza
    Aniko Szabo
    Carolina Schinke
    Rajshekhar Chakraborty
    Blood Cancer Journal, 14
  • [6] Teclistamab in Relapsed Refractory Multiple Myeloma: Multi-Institutional Real-World Study
    Mohan, Meera
    Shah, Nishi
    Luan, Danny
    Monge, Jorge
    Forsberg, Mark
    Bhatlapenumarthi, Vineel
    Balev, Metodi
    Patwari, Anannya
    Cheruvalath, Heloise
    Bhutani, Divaya
    Thanendrarajan, Sharmilan
    Dhakal, Binod
    Zangari, Maurizio
    Al Hadidi, Samer
    Cooper, Dennis L.
    Lentzsch, Suzanne
    van Rhee, Frits
    D'Souza, Anita
    Szabo, Aniko
    Schinke, Carolina
    Chakraborty, Rajshekhar
    BLOOD, 2023, 142
  • [7] Teclistamab in relapsed refractory multiple myeloma: multi-institutional real-world study
    Mohan, Meera
    Monge, Jorge
    Shah, Nishi
    Luan, Danny
    Forsberg, Mark
    Bhatlapenumarthi, Vineel
    Balev, Metodi
    Patwari, Anannya
    Cheruvalath, Heloise
    Bhutani, Divaya
    Thanendrarajan, Sharmilan
    Dhakal, Binod
    Zangari, Maurizio
    Al-Hadidi, Samer
    Cooper, Dennis
    Lentzsch, Suzanne
    van Rhee, Frits
    D'Souza, Anita
    Szabo, Aniko
    Schinke, Carolina
    Chakraborty, Rajshekhar
    BLOOD CANCER JOURNAL, 2024, 14 (01)
  • [8] Real-world evaluation of teclistamab for the treatment of relapsed/refractory multiple myeloma (RRMM): an International Myeloma Working Group Study
    Tan, Carlyn Rose
    Asoori, Sireesha
    Huang, Chiung-Yu
    Brunaldi, Larissa
    Popat, Rakesh
    Kastritis, Efstathios
    Martinez-Lopez, Joaquin
    Bansal, Radhika
    Corraes, Andre De Menezes Silva
    Chhabra, Saurabh
    Parrondo, Ricardo
    Ailawadhi, Sikander
    Fotiou, Despina
    Dimopoulos, Meletios A.
    Yong, Kwee
    Mactier, Catriona
    Lau, Chris
    Corona, Magdalena
    Marin, Adolfo Jesus Saez
    Mian, Hira
    Durie, Brian GM.
    Usmani, Saad Z.
    Martin, Thomas G.
    Lin, Yi
    BLOOD CANCER JOURNAL, 2025, 15 (01):
  • [9] Real-World Experience with Teclistamab for Relapsed/ Refractory Multiple Myeloma from the US Myeloma Immunotherapy Consortium
    Razzo, Beatrice
    Grajales-Cruz, Ariel
    Atrash, Shebli
    Ferreri, Christopher
    Goyal, Anmol
    Pasvolsky, Oren
    Banerjee, Rahul
    Julian, Kelley
    Forsberg, Peter
    Herr, Megan
    Lin, Yi
    Susanibar-Adaniya, Sandra
    Khouri, Jack
    Vazquez-Martinez, Mariola
    Lee, Hans
    Portuguese, Andrew
    Sborov, Douglas W.
    Dima, Danai
    Davis, James
    Kaur, Gurbakhash
    Shune, Leyla
    Hansen, Doris
    Sidana, Surbhi
    Garfall, Alfred
    Richard, Shambavi
    CLINICAL LYMPHOMA MYELOMA & LEUKEMIA, 2024, 24 : S82 - S83
  • [10] Teclistamab in Relapsed/Refractory Multiple Myeloma: Real-World Outcomes at a Single Academic Center in the Midwest
    Stepanovic, Adam
    Abonour, Rafat
    Abu Zaid, Mohammad
    Farag, Sherif
    Lee, Kelvin P.
    Suvannasankha, Attaya
    BLOOD, 2023, 142
12345